Vermeulen Maxime, Poels Jonathan, de Michele Francesca, des Rieux Anne, Wyns Christine
Gynecology-Andrology Research Unit, Medical School, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, 1200, Brussels, Belgium.
Department of Gynecology-Andrology, Université Catholique de Louvain, Cliniques Universitaires Saint-Luc, Avenue Hippocrate 10, 1200, Brussels, Belgium.
Ann Biomed Eng. 2017 Jul;45(7):1770-1781. doi: 10.1007/s10439-017-1789-5. Epub 2017 Jan 9.
New and improved oncological therapies are now able to cure more than 80% of cancer-affected children in Europe. However, such treatments are gonadotoxic and result in fertility issues, especially in boys who are not able to provide a sperm sample before starting chemo/radiotherapy because of their prepubertal state. For these boys, cryopreservation of immature testicular tissue (ITT) is the only available option, aiming to preserve spermatogonial stem cells (SSCs). Both slow-freezing and vitrification have been investigated to this end and are now applied in a clinical setting for SSC cryopreservation. Research now has to focus on methods that will allow fertility restoration. This review discusses different studies that have been conducted on ITT transplantation, including those using growth factor supplementation like free molecules, or tissue encapsulation with or without nanoparticles, as well as the possibility of developing a bioartificial testis that can be used for in vitro gamete production or in vivo transplantation.
在欧洲,新型且改良的肿瘤治疗方法如今能够治愈超过80%患癌儿童。然而,此类治疗具有性腺毒性,会导致生育问题,尤其是对于那些因处于青春期前状态而无法在开始化疗/放疗前提供精子样本的男孩。对于这些男孩而言,冷冻保存未成熟睾丸组织(ITT)是唯一可行的选择,旨在保存精原干细胞(SSC)。为此,慢速冷冻和玻璃化冷冻均已得到研究,目前已应用于临床环境中进行SSC冷冻保存。现在研究必须聚焦于能够实现生育力恢复的方法。本综述讨论了针对ITT移植开展的不同研究,包括那些使用游离分子等生长因子补充剂,或有无纳米颗粒的组织封装的研究,以及开发可用于体外配子生成或体内移植的生物人工睾丸的可能性。